RxDoctor Payments Data

Michael Porayko

Gastroenterology · Nashville, TNNPI 1033206149

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $11,974 of the $12,147 with a category attached, or 98.6%. Mallinckrodt Hospital Products Inc. accounts for 77.8% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2021 at $6,248 and has fallen 93.4% since, to $413 in 2024.

$12,147in general payments, 2019–2025

Across 10 payments — averaging $1214.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mallinckrodt Hospital Products Inc.$9K
  • Novo Nordisk$1K
  • Gilead$550
  • Vertex$413
  • Insmed, Inc.$413
  • Mallinckrodt Enterprises LLC$73
$857,862in research payments, 2019–2025

Across 220 payments — averaging $3899.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Intercept Pharmaceuticals, Inc.$462K
  • Mallinckrodt Enterprises LLC$130K
  • AbbVie$116K
  • E.r. Squibb & Sons, L.L.C.$65K
  • Pfizer$56K
  • Gilead$18K
  • plus $11K from 3 others

What the payments were for

  • Consulting fees$11,97499%
  • Food & beverage$1731%

General payments by program year

19
20
21
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$12,147 in reported general payments places this provider in the 85th percentile of 336 gastroenterology providers in Tennessee.

See all gastroenterology providers in Tennessee

Other gastroenterology in Nashville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →